Clyde Biosciences secures new investment
17-Apr-2015 -
Clyde Biosciences Ltd. has announced a £2 million ‘Series A’ investment led by Epidarex Capital, a leading international early-stage life science venture capital fund. Scottish Enterprise’s investment arm, the Scottish Investment Bank, also participated in the round along with Glasgow University ...
drug toxicity
induced pluripotent stem cells
Series A financing